Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Transgender women and HIV-related health disparities: falling off the HIV treatment cascade

Seth C. Kalichman A B , Dominica Hernandez A , Stephanie Finneran A , Devon Price A and Redd Driver A
+ Author Affiliations
- Author Affiliations

A Department of Psychology, University of Connecticut, 406 Babbidge Road, Storrs, CT 06269.

B Corresponding author. Email: seth.k@uconn.edu

Sexual Health 14(5) 469-476 https://doi.org/10.1071/SH17015
Submitted: 28 January 2017  Accepted: 18 May 2017   Published: 5 September 2017

Abstract

Background: Transgender women living with HIV infection experience poorer health outcomes across the HIV continuum of care. While disparities are well established, their underlying mechanisms are not well understood. This study examined the HIV continuum of care (also known as the HIV treatment cascade), including linkage and engagement in care and health status among transgender women and cisgender women and cisgender men living with HIV. Method: Case-control matching was applied to a cohort of 1101 people living with HIV; 70 transgender women living with HIV were matched on years since testing HIV positive with cisgender women and cisgender men. Participants provided measures indicative of the HIV treatment cascade that included linkage and engagement in care, receiving and adhering to antiretroviral therapy (ART), and HIV viral suppression. Common correlates of HIV-related health status: depression symptoms, HIV-related stress, alcohol and drug use, healthcare conspiracy beliefs, medical mistrust, emotional social support and tangible social support, were also assessed. Results: Transgender women were significantly less likely to receive ART, were less adherent to ART and had poorer HIV viral suppression than cisgender persons. Multivariable models demonstrated that health disparities were predicted by transgender women having poorer tangible social support over and above the other correlates of health outcomes. Conclusion: Tangible support is amenable by interventions such as building and strengthening supportive networks and paraprofessional services. Socially supportive interventions should be considered critical in efforts to decrease HIV health disparities among transgender women.

Additional keywords: HIV infection, HIV treatment, linkage to care, adherence, care continuum.


References

[1]  Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2013. Atlanta: CDC; 2015.

[2]  Centers for Disease Control and Prevention. HIV among gay and bisexual men. Available online at: http://www.cdc.gov/hiv/group/msm [verified 1 February 2017].

[3]  Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr 2016; 72 S210–9.
Global epidemiology of HIV infection and related syndemics affecting transgender people.CrossRef |

[4]  Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, Holland CE, Max R, Baral SD. Global health burden and needs of transgender populations: a review. Lancet 2016; 388 412–36.
Global health burden and needs of transgender populations: a review.CrossRef |

[5]  Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13 214–22.
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.CrossRef |

[6]  Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N, HIV/AIDS Prevention Research Synthesis Team Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav 2008; 12 1–17.
Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review.CrossRef |

[7]  Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52 793–800.
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.CrossRef |

[8]  Barrington C. Understanding and addressing human immunodeficiency virus and sexually transmitted disease disparities among transgender persons. Sex Transm Dis 2016; 43 412–3.
Understanding and addressing human immunodeficiency virus and sexually transmitted disease disparities among transgender persons.CrossRef |

[9]  Barrington C, Knudston K, Bailey OA, Aguilar JM, Loya-Montiel MI, Morales-Miranda S. HIV diagnosis, linkage to care, and retention among men who have sex with men and transgender women in Guatemala City. J Health Care Poor Underserved 2016; 27 1745–60.
HIV diagnosis, linkage to care, and retention among men who have sex with men and transgender women in Guatemala City.CrossRef |

[10]  Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009–2014. AIDS Behav 2016;
Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009–2014.CrossRef |

[11]  Wiewel EW, Torian LV, Merchant P, Braunstein SL, Shepard CW. HIV diagnoses and care among transgender persons and comparison with men who have sex with men: New York City, 2006–2011. Am J Public Health 2016; 106 497–502.
HIV diagnoses and care among transgender persons and comparison with men who have sex with men: New York City, 2006–2011.CrossRef |

[12]  Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS 2014; 9 168–73.
HIV epidemics among transgender women.CrossRef |

[13]  Reback CJ, Ferlito D, Kisler KA, Fletcher JB. Recruiting, linking, and retaining high-risk transgender women into HIV prevention and care services: an overview of barriers, strategies, and lessons learned. Int J Transgenderism 2015; 16 209–21.
Recruiting, linking, and retaining high-risk transgender women into HIV prevention and care services: an overview of barriers, strategies, and lessons learned.CrossRef |

[14]  Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med 2014; 47 5–16.
Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus.CrossRef |

[15]  Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care 2010; 21 256–64.
Antiretroviral therapy adherence among transgender women living with HIV.CrossRef |

[16]  Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care 2016; 28 976–81.
Medication adherence among transgender women living with HIV.CrossRef |

[17]  Mizuno Y, Frazier EL, Huang P, Skarbinski J. Characteristics of transgender women living with HIV receiving medical care in the United States. LGBT Health 2015; 2 228–34.
Characteristics of transgender women living with HIV receiving medical care in the United States.CrossRef |

[18]  Santos GM, Wilson EC, Rapues J, Macias O, Packer T, Raymond HF. HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect 2014; 90 430–3.
HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study.CrossRef |

[19]  Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, Rubin D, Adolescent Medicine Trials Network for HIV/AIDS Interventions Behavioral and health outcomes for HIV+ young transgender women (YTW) linked to and engaged in medical care. LGBT Health 2016; 3 162–7.
Behavioral and health outcomes for HIV+ young transgender women (YTW) linked to and engaged in medical care.CrossRef |

[20]  Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav 2007; 11 85–100.
The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature.CrossRef |

[21]  Holtgrave DR, Briddell K, Little E, Bendixen AV, Hooper M, Kidder DP, Wolitski RJ, Harre D, Royal S, Aidala A. Cost and threshold analysis of housing as an HIV prevention intervention. AIDS Behav 2007; 11 162–6.
Cost and threshold analysis of housing as an HIV prevention intervention.CrossRef |

[22]  Kidder DP, Wolitski RJ, Royal S, Aidala A, Courtenay-Quirk C, Holtgrave DR, Harre D, Sumartojo E, Stall R, Housing and Health Study Team Access to housing as a structural intervention for homeless and unstably housed people living with HIV: rationale, methods, and implementation of the housing and health study. AIDS Behav 2007; 11 149–61.
Access to housing as a structural intervention for homeless and unstably housed people living with HIV: rationale, methods, and implementation of the housing and health study.CrossRef |

[23]  Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q 2003; 17 423–41.
Syndemics and public health: reconceptualizing disease in bio-social context.CrossRef |

[24]  Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008; 70 539–45.
Role of depression, stress, and trauma in HIV disease progression.CrossRef |

[25]  Leserman J, Barroso J, Pence BW, Salahuddin N, Harmon JL. Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care 2008; 20 1258–65.
Trauma, stressful life events and depression predict HIV-related fatigue.CrossRef | 1:STN:280:DC%2BD1cjktV2jtg%3D%3D&md5=f536993339ec74461a41df8bcc451101CAS |

[26]  Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr 2011; 58 181–7.
Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.CrossRef |

[27]  Kalichman SC, Kalichman MO, Cherry C, Hoyt G, Washington C, Grebler T, Welles B, Merely C. Intentional medication nonadherence because of interactive toxicity beliefs among HIV-positive active drug users. J Acquir Immune Defic Syndr 2015; 70 503–9.
Intentional medication nonadherence because of interactive toxicity beliefs among HIV-positive active drug users.CrossRef | 1:CAS:528:DC%2BC2MXhvVOrsbfE&md5=3b05993005a183860e9324fbce432fcbCAS |

[28]  Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care. Curr HIV/AIDS Rep 2015; 12 421–36.
The impact of alcohol use and related disorders on the HIV continuum of care: a systematic review: alcohol and the HIV continuum of care.CrossRef |

[29]  Bogart LM, Wagner G, Galvan F, Trombacco K. D. B, editors. Association of HIV-specific medical mistrust to treatment adherence among African American men with HIV. 3rd International Conference on HIV Treatment Adherence; 1 June 2008 ; Jersey City, NJ.

[30]  Eaton LA, Driffin DD, Kegler C, Smith H, Conway-Washington C, White D, Cherry C. The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men. Am J Public Health 2015; 105 e75–82.
The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men.CrossRef |

[31]  Brenick A, Romano K, Kegler C, Eaton LA. Understanding the influence of stigma and medical mistrust on engagement in routine healthcare among black women who have sex with women. LGBT Health 2017; 4 4–10.
Understanding the influence of stigma and medical mistrust on engagement in routine healthcare among black women who have sex with women.CrossRef |

[32]  White Hughto JM, Murchison GR, Clark K, Pachankis JE, Reisner SL. Geographic and individual differences in healthcare access for U.S. transgender adults: a multilevel analysis. LGBT Health 2016; 3 424–33.
Geographic and individual differences in healthcare access for U.S. transgender adults: a multilevel analysis.CrossRef |

[33]  Kelly JD, Hartman C, Graham J, Kallen MA, Giordano TP. Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study. J Assoc Nurses AIDS Care 2014; 25 405–13.
Social support as a predictor of early diagnosis, linkage, retention, and adherence to HIV care: results from the steps study.CrossRef |

[34]  Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nerv Ment Dis 2000; 188 662–70.
Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS.CrossRef | 1:STN:280:DC%2BD3crgtFersQ%3D%3D&md5=f56f27bd38c6124e37b091f274e63da4CAS |

[35]  Cha YJ, Park Q, Kang ES, Yoo BC, Park KU, Kim JW, Hwang YS, Kim MH. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med 2013; 33 184–9.
Performance evaluation of the OraQuick hepatitis C virus rapid antibody test.CrossRef | 1:CAS:528:DC%2BC3sXpsVyjsbs%3D&md5=af9ef36c339c48f34a84c828ae1f9c17CAS |

[36]  Saberi P, Johnson MO. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care 2015; 27 660–4.
Moving toward a novel and comprehensive behavioral composite of engagement in HIV care.CrossRef |

[37]  Kalichman SC, Amaral CM, Stearns H, White D, Flanagan J, Pope H, Cherry C, Cain D, Eaton L, Kalichman MO. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med 2007; 22 1003–6.
Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone.CrossRef |

[38]  Kalichman SC, Amaral CM, Cherry C, Flanagan JA, Pope H, Eaton L, Kalichman MO, Cain D, Detorio M, Caliendo A, Schinazi RF. Monitoring antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials 2008; 9 298–308.
Monitoring antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity.CrossRef |

[39]  Kalichman SC, Amaral C, Swetsze C, Eaton L, Kalichman MO, Cherry C, Detorio M, Caliendo AM, Schinazi RF. Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects. HIV Clin Trials 2010; 11 325–31.
Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects.CrossRef |

[40]  Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav 2001; 5 275–81.
Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts.CrossRef |

[41]  Haberer JE, Robbins GK, Ybarra M, Monk A, Ragland K, Weiser SD, Johnson MO, Bangsberg DR. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav 2012; 16 375–82.
Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable.CrossRef |

[42]  Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med 2002; 17 812–3.
Is average adherence to HIV antiretroviral therapy enough?CrossRef |

[43]  Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, Montaner JS. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr 2010; 55 460–5.
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.CrossRef | 1:CAS:528:DC%2BC3cXhtl2ltLzN&md5=acf750694e195f40a10974ef7bf69da4CAS |

[44]  Simoni JM, Huh D, Wilson IB, Goggin K, Reynolds NR, Remien RH, Rosen MI, Bangsberg DR, Liu H. Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 Study. J Acquir Immune Defic Syndr 2012; 60 466–72.
Racial/ethnic disparities in ART adherence in the United States: findings from the MACH14 Study.CrossRef |

[45]  Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, Beckwith CG, Dowshen N, Gordon CM, Horn T, Kumar P, Scott JD, Stirratt MJ, Remien RH, Simoni JM, Nachega JB. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care Panel. Ann Intern Med 2012; 156 817–33.
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care Panel.CrossRef |

[46]  Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1 385–401.
The CES-D Scale: a self-report depression scale for research in the general population.CrossRef |

[47]  Chesney M, Folkman S, Chambers D. Coping effectiveness training for men living with HIV: preliminary findings. Int J STD AIDS 1996; 7 75–82.
Coping effectiveness training for men living with HIV: preliminary findings.CrossRef |

[48]  Kalichman SC, DiMarco M, Austin J, Luke W, DiFonzo K. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med 2003; 26 315–32.
Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women.CrossRef |

[49]  Maisto SA, Conigliaro J, McNeil M, Kraemer K, Kelley ME. An empirical investigation of the factor structure of the AUDIT. Psychol Assess 2000; 12 346–53.
An empirical investigation of the factor structure of the AUDIT.CrossRef | 1:STN:280:DC%2BD3cvmslOktw%3D%3D&md5=20022b89beafd00e7f1052ccd4f049bdCAS |

[50]  Braithwaite RS, McGinnis K, Conigliaro J, Maisto SA, Crystal S, Day N, Cook RL, Gordon A, Bridges MW, Seiler JF, Justice AC. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res 2005; 29 1190–7.
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care.CrossRef |

[51]  LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev 2000; 57 146–61.
Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients.CrossRef |

[52]  Anderson AD. Therapeutic trust. J Chronic Dis 1982; 35 817–20.
Therapeutic trust.CrossRef | 1:STN:280:DyaL3s%2Flslaktg%3D%3D&md5=e3f5417c9f4851938f9302877b6dde03CAS |

[53]  Brock D, Sarason I, Sarason B, Pierce G. Simultaneous assessment of perceived global and relationship-specific support. J Soc Pers Relat 1996; 13 143–52.
Simultaneous assessment of perceived global and relationship-specific support.CrossRef |

[54]  Morrison-Beedy D, Carey MP, Tu X. Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior. AIDS Behav 2006; 10 541–52.
Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior.CrossRef |

[55]  Reisner SL, White JM, Bradford JB, Mimiaga MJ. Transgender health disparities: comparing full cohort and nested matched-pair study designs in a community health center. LGBT Health 2014; 1 177–84.
Transgender health disparities: comparing full cohort and nested matched-pair study designs in a community health center.CrossRef |

[56]  Bottonari KA, Roberts JE, Ciesla JA, Hewitt RG. Life stress and adherence to antiretroviral therapy among HIV-positive individuals: a preliminary investigation. AIDS Patient Care STDS 2005; 19 719–27.
Life stress and adherence to antiretroviral therapy among HIV-positive individuals: a preliminary investigation.CrossRef |

[57]  Bottonari KA, Safren SA, McQuaid JR, Hsiao CB, Roberts JE. A longitudinal investigation of the impact of life stress on HIV treatment adherence. J Behav Med 2010; 33 486–95.
A longitudinal investigation of the impact of life stress on HIV treatment adherence.CrossRef |

[58]  Kidman R, Nice J, Taylor T, Thurman TR. Home visiting programs for HIV-affected families: a comparison of service quality between volunteer-driven and paraprofessional models. Vulnerable Child Youth Stud 2014; 9 305–17.
Home visiting programs for HIV-affected families: a comparison of service quality between volunteer-driven and paraprofessional models.CrossRef |

[59]  Thurman TR, Kidman R, Taylor TM. Does investment in home visitors lead to better psychological health for HIV-affected families? Results from a quasi-experimental evaluation in South Africa. AIDS Care 2014; 26 S2–10.
Does investment in home visitors lead to better psychological health for HIV-affected families? Results from a quasi-experimental evaluation in South Africa.CrossRef |


Full Text PDF (162 KB) Export Citation

View Altmetrics